Dolby Laboratories Affirms FY2025 Adj EPS Guidance of $3.88-$4.03 vs $3.97 Est; Narrows FY2025 Sales Guidance from $1.31B-$1.38B to $1.33B-$1.36B vs $1.34B Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Dolby Laboratories (NYSE:DLB) affirms FY2025 Adj EPS guidance from $3.88-$4.03 to $3.88-$4.03 vs $3.97 analyst estimate. Narrows FY2025 sales outlook from $1.31 billion-$1.38 billion to $1.33 billion-$1.36 billion vs
Dolby Laboratories (NYSE:DLB) affirms FY2025 Adj EPS guidance from $3.88-$4.03 to $3.88-$4.03 vs $3.97 analyst estimate. Narrows FY2025 sales outlook from $1.31 billion-$1.38 billion to $1.33 billion-$1.36 billion vs $1.34 billion estimate.